BioCT welcomes two new members to its Board of Directors.
Mostafa Analoui, Ph.D., is Executive Director of Venture Development and Technology Incubation Program (TIP) at UConn. Previously, he was Head of Healthcare and Life Sciences at Livingston Securities (New York, NY) with investment focus in private and public companies in biotech, medtech and healthcare services. Prior to that, he was the Senior Director at Pfizer Global Research and Development. Dr. Analoui is actively involved in investment, management and scientific/business development of nanotechnology, drug discovery/development, diagnostic imaging, and global strategies … more
Carine Boustany is the U.S. Department Head of Cardiometabolic Diseases Research at Boehringer Ingelheim. In this role, Carine is responsible for leading a team of scientists focused on delivering innovative therapies that will make a meaningful difference in the lives of patients suffering from cardiometabolic disease. Prior to joining BI in 2011, Carine was a researcher at Pfizer where she led project teams in diabetes and diabetic nephropathy. Notably, Carine led the biology team that discovered and advanced to the clinic ertugliflozin, a novel anti-diabetic recently registered as Steglatro … more